DSpace UNL

RUN >
Nova School of Business and Economics (NSBE) >
NSBE: Economia e Gestão >
NSBE: Economia e Gestão >
NSBE: EG - Artigos em revista internacional com arbitragem científica >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10362/2512

Title: On international cost-sharing of pharmaceutical R&D
Authors: Barros, Pedro
Martinez-Giralt, Xavier
Keywords: Ramsey pricing, coinsurance.
Issue Date: Dec-2008
Publisher: Springer Netherlands
Abstract: Ramsey pricing has been proposed in the pharmaceutical industry as a principle to price discriminate among markets while allowing to recover the (fixed) R&D cost. However, such analyses neglect the presence of insurance or the fund raising costs for most of drug reimbursement. By incorporating these new elements, we aim at providing some building blocks towards an economic theory incorporating Ramsey pricing and insurance coverage. We show how coinsurance affects the optimal prices to pay for the R&D investment. We also show that under certain conditions, there is no strategic incentive by governments to set coinsurance rates in order to shift the financial burden of R&D. This will have important implications to the application of Ramsey pricing principles to pharmaceutical products across countries.
URI: http://hdl.handle.net/10362/2512
ISSN: 1389-6563
Appears in Collections:NSBE: EG - Artigos em revista internacional com arbitragem científica

Files in This Item:

File Description SizeFormat
RamseyPharmaceuticalsv11.pdf154.06 kBAdobe PDFView/Open
Statistics
View Statistics
FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpaceOrkut
Formato BibTex mendeley Endnote Logotipo do DeGóis 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Universidade Nova de Lisboa  - Statistics  - Feedback
Estamos no RCAAP Governo Português separator Ministério da Educação e Ciência   Fundação para a Ciência e a Tecnologia

Financiado por:

POS_C UE